Figure 7B represents one dataset analyzed in Figure 7A, the vandeVijver breast carcinoma study, and shows that BRF2 overexpression is highly significant in patients presenting with metastasis at year 1, p-value = 0.034, and at year 5, p-value = 0.006. The gene discussed is BRF2; the disease is breast carcinoma.